Lyanne M. Kieneker
Lyanne M. Kieneker
University Medical Center Groningen
Verified email at umcg.nl
Title
Cited by
Cited by
Year
Heart failure stimulates tumor growth by circulating factors
WC Meijers, M Maglione, SJL Bakker, R Oberhuber, LM Kieneker, ...
Circulation 138 (7), 678-691, 2018
852018
Urinary potassium excretion and risk of developing hypertension: the prevention of renal and vascular end-stage disease study
LM Kieneker, RT Gansevoort, KJ Mukamal, RA de Boer, G Navis, ...
Hypertension 64 (4), 769-776, 2014
602014
Low potassium excretion but not high sodium excretion is associated with increased risk of developing chronic kidney disease
LM Kieneker, SJL Bakker, RA de Boer, GJ Navis, RT Gansevoort, ...
Kidney international 90 (4), 888-896, 2016
502016
Plasma branched-chain amino acids and risk of incident type 2 diabetes: results from the PREVEND prospective cohort study
JL Flores-Guerrero, MCJ Osté, LM Kieneker, EG Gruppen, ...
Journal of clinical medicine 7 (12), 513, 2018
272018
Urinary potassium excretion and risk of cardiovascular events
PREVEND Study Group Kieneker Lyanne M Gansevoort Ron T Boer Rudolf A de ...
The American journal of clinical nutrition 103 (5), 1204-1212, 2016
272016
Urinary potassium excretion, renal ammoniagenesis, and risk of graft failure and mortality in renal transplant recipients
MF Eisenga, LM Kieneker, SS Soedamah-Muthu, E Van Den Berg, ...
The American journal of clinical nutrition 104 (6), 1703-1711, 2016
252016
Plasma copeptin and chronic kidney disease risk in 3 European cohorts from the general population
R El Boustany, I Tasevska, E Meijer, LM Kieneker, S Enhörning, G Lefèvre, ...
JCI insight 3 (13), 2018
192018
Incident type 2 diabetes is associated with HDL, but not with its anti-oxidant constituent-paraoxonase-1: the prospective cohort PREVEND study
SK Kunutsor, LM Kieneker, SJL Bakker, RW James, RPF Dullaart
Metabolism 73, 43-51, 2017
192017
Association of low urinary sodium excretion with increased risk of stroke
LM Kieneker, MF Eisenga, RT Gansevoort, RA de Boer, G Navis, ...
Mayo Clinic Proceedings 93 (12), 1803-1809, 2018
162018
Plasma potassium, diuretic use and risk of developing chronic kidney disease in a predominantly White population
LM Kieneker, MF Eisenga, MM Joosten, RA de Boer, RT Gansevoort, ...
PloS one 12 (3), e0174686, 2017
162017
COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration
LB Hilbrands, R Duivenvoorden, P Vart, CFM Franssen, MH Hemmelder, ...
Nephrology Dialysis Transplantation 35 (11), 1973-1983, 2020
142020
Circulating total bilirubin and future risk of hypertension in the general population: the prevention of renal and vascular end‐stage disease (PREVEND) prospective study and a …
SK Kunutsor, LM Kieneker, S Burgess, SJL Bakker, RPF Dullaart
Journal of the American Heart Association 6 (11), e006503, 2017
142017
Lipoprotein insulin resistance index, a high-throughput measure of insulin resistance, is associated with incident type II diabetes mellitus in the prevention of renal and …
JL Flores-Guerrero, MA Connelly, I Shalaurova, EG Gruppen, ...
Journal of clinical lipidology 13 (1), 129-137. e1, 2019
122019
Self‐Reported smoking, urine cotinine, and risk of cardiovascular disease: findings from the PREVEND (Prevention of Renal and Vascular End‐Stage Disease) prospective cohort study
SK Kunutsor, JM Spee, LM Kieneker, RT Gansevoort, RPF Dullaart, ...
Journal of the American Heart Association 7 (10), e008726, 2018
122018
Plasma proenkephalin and poor long-term outcome in renal transplant recipients
LM Kieneker, O Hartmann, J Struck, A Bergmann, RT Gansevoort, ...
Transplantation direct 3 (8), 2017
122017
Active smoking and hematocrit and fasting circulating erythropoietin concentrations in the general population
MF Eisenga, LM Kieneker, DJ Touw, IM Nolte, P van der Meer, G Huls, ...
Mayo Clinic Proceedings 93 (3), 337-343, 2018
102018
The inverse association of HDL-cholesterol with future risk of hypertension is not modified by its antioxidant constituent, paraoxonase-1: The PREVEND prospective cohort study
SK Kunutsor, LM Kieneker, SJL Bakker, RW James, RPF Dullaart
Atherosclerosis 263, 219-226, 2017
92017
GlycA, a novel pro‐inflammatory glycoprotein biomarker is associated with mortality: results from the PREVEND study and meta‐analysis
EG Gruppen, SK Kunutsor, LM Kieneker, B van der Vegt, MA Connelly, ...
Journal of internal medicine 286 (5), 596-609, 2019
82019
Plasma neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease: Findings from the PREVEND prospective cohort study
SK Kunutsor, JL Flores-Guerrero, LM Kieneker, T Nilsen, C Hidden, ...
Clinica chimica acta 486, 66-75, 2018
72018
Educational level and risk of chronic kidney disease: longitudinal data from the PREVEND study
CHL Thio, P Vart, LM Kieneker, H Snieder, RT Gansevoort, U Bültmann
Nephrology Dialysis Transplantation 35 (7), 1211-1218, 2020
62020
The system can't perform the operation now. Try again later.
Articles 1–20